Real-World Clinical Profile of Patients Prescribed Evolocumab in Japan

Sheng, Feng; Wang, Alex; Miyawaki, Kazumasa; Tsuchiya, Takahiro; Osada, Nobuhiro; Miller, Russell; Fu, Ziyang; Okamura, Tomonori

doi:10.1253/circj.cj-23-0814

Public

Real-World Clinical Profile of Patients Prescribed Evolocumab in Japan

Published in Circulation Journal • Feb 29, 2024

Authors:

Feng Sheng

Alex Wang

Kazumasa Miyawaki

Abstract

BACKGROUND: Real-world utilization data for evolocumab, the first proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor to be introduced in Japan in 2016, to date are limited. This study aimed to clarify the current real-world patient user profiles of evolocumab based on large-scale health...

Subject

Evolocumab

Medicine

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!